- Namilumab
-
Namilumab ? Monoclonal antibody Type Whole antibody Source Human Target CSF2 Clinical data Pregnancy cat. ? Legal status ? Identifiers CAS number 1226761-65-4 ATC code None UNII MED485W763 Chemical data Formula ? (what is this?) (verify) Namilumab is an immunomodulator. It binds to CSF2.[1]
References
- ^ World Health Organization (2010). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 104" (PDF). WHO Drug Information 24 (4). http://www.who.int/medicines/publications/druginformation/innlists/Final_PL104.pdf.
Monoclonal antibodies for the immune system Immune system ("-l(i[m])-") Interleukin ("-k(i[n])-") Human ("-kinu-")Briakinumab • Canakinumab • Fezakinumab • Secukinumab • Sirukumab • Tralokinumab • UstekinumabHumanized ("-kizu-", "-kinzu-")Anrukinzumab • Enokizumab • Gevokizumab • Ixekizumab • Lebrikizumab • OlokizumabInflammatory lesions ("-les-") Mouse ("-leso-")This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it. This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.